Its not a side effect, but rather using the same pathway it uses to suppress your appetite
That said, the exact timeline for experiencing the benefits is related to the nature of the condition or injury being addressed
Factors that may influence individual susceptibility include: Treatment duration: Symptoms often emerge during the titration phase when the body is adjusting to the medication Dose level: The maintenance dose of Saxenda is 3.0 mg once daily, and gastrointestinal effects may be more pronounced at this dose compared to lower titration doses Dietary habits: Patients consuming high-protein, low-carbohydrate diets may be more prone to sulphur-related symptoms Pre-existing digestive conditions: Those with irritable bowel syndrome or other gastrointestinal disorders may experience more symptoms Most gastrointestinal side effects of Saxenda, including potential eggy burps, tend to improve over time as the body adapts to the medication
Studies have shown that BPC-157 [8]: Modulates GABA receptor function Influences dopaminergic system activity Affects serotonergic pathways May help normalize neurotransmitter imbalances caused by various toxins These effects contribute to BPC-157's observed: Anxiolytic (anti-anxiety) properties in animal models Protection against dopaminergic neurotoxins Potential applications in alcohol withdrawal and drug-induced neurological damage Gut motility regulation Angiogenesis Promotion Beyond VEGF upregulation, BPC-157 promotes angiogenesis through multiple coordinated mechanisms [9]: Direct stimulation of endothelial cell proliferation Enhanced endothelial cell migration Improved capillary tube formation Blood vessel maturation and stabilization Collateral vessel development around blocked arteries This robust angiogenic effect helps explain why BPC-157 appears effective for tissues with naturally poor blood supply (tendons, ligaments, cartilage) and why it may support recovery from ischemic injuries
We were founded on the principle that patients should have direct access to proven, effective treatments without an insurance company acting as a gatekeeper
The rise of the GLP-1 patch directly addresses some of the most common hurdles we've encountered over the years
